Nu Skin Enterprises (NYSE:NUS – Get Free Report) updated its fourth quarter earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.19 to $0.29 for the period, compared to the consensus estimate of $0.28. The company issued revenue guidance of $410 million to $445 million, compared to the consensus revenue estimate of $455.83 million.
Analyst Ratings Changes
Several analysts recently weighed in on NUS shares. Citigroup dropped their price objective on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research report on Tuesday, October 22nd. DA Davidson dropped their target price on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a report on Monday, August 12th. Finally, StockNews.com lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Wednesday, October 23rd.
View Our Latest Research Report on Nu Skin Enterprises
Nu Skin Enterprises Price Performance
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.04. Nu Skin Enterprises had a positive return on equity of 7.80% and a negative net margin of 8.05%. The company had revenue of $439.10 million for the quarter, compared to analysts’ expectations of $431.87 million. During the same period in the previous year, the business posted $0.54 earnings per share. The business’s quarterly revenue was down 12.2% compared to the same quarter last year. As a group, analysts expect that Nu Skin Enterprises will post 0.78 EPS for the current fiscal year.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading
- Five stocks we like better than Nu Skin Enterprises
- 3 Healthcare Dividend Stocks to Buy
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What does consumer price index measure?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- What is the S&P 500 and How It is Distinct from Other Indexes
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.